Lexaria Bioscience Corp. - Common Stock (NQ:LEXX)Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
Lexaria Enters a Material Transfer Agreement With PegBio
August 13, 2026
Lexaria Announces Effective Date for Reverse Stock Split
July 30, 2026
Lexaria Updates Business Development
July 06, 2026
Lexaria Updates Progress on Human Study #7
May 05, 2026
Wednesday's session: top gainers and losers ↗
April 29, 2026
Lexaria Applauds Eli Lilly's Foundayo(TM) Drug Approval
April 07, 2026
Lexaria Applauds Eli Lilly's Foundayo(TM) Drug Approval
April 07, 2026
Lexaria to Begin New Human Clinical Study in GLP-1
April 01, 2026
Lexaria's Robust Patent Portfolio Continues to Grow
March 26, 2026
Frequently Asked QuestionsIs Lexaria Bioscience Corp. - Common Stock publicly traded?
Yes, Lexaria Bioscience Corp. - Common Stock is publicly traded.
What exchange does Lexaria Bioscience Corp. - Common Stock trade on?
Lexaria Bioscience Corp. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lexaria Bioscience Corp. - Common Stock?
The ticker symbol for Lexaria Bioscience Corp. - Common Stock is LEXX on the Nasdaq Stock Market
What is the current price of Lexaria Bioscience Corp. - Common Stock?
The current price of Lexaria Bioscience Corp. - Common Stock is 12.12
When was Lexaria Bioscience Corp. - Common Stock last traded?
The last trade of Lexaria Bioscience Corp. - Common Stock was at 09/01/26 12:30 PM ET
What is the market capitalization of Lexaria Bioscience Corp. - Common Stock?
The market capitalization of Lexaria Bioscience Corp. - Common Stock is 301.64M
How many shares of Lexaria Bioscience Corp. - Common Stock are outstanding?
Lexaria Bioscience Corp. - Common Stock has 302M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
|
